Suchergebnisse - "Shao, Jingwei"

PubPharm (151)

41

Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles

enthalten in: Nature communications | 2019

von Xie, X. | Nie, H. | Zhou, Y. | +15

ErratumIn: Nat Commun. 2020 Jan 8;11(1):243. - PMID 31913267

42

Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma

enthalten in: European journal of medicinal chemistry | 2019

von Chen, F. | Fang, Y. | Zhao, R. | +5

43

Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity

enthalten in: Journal of computer-aided molecular design | 2019

von Zhu, K. | Shao, J. | Tao, H. | +4

44

Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity

enthalten in: Journal of computer aided molecular design | 2019

von Zhu, K. | Shao, J. | Tao, H. | +4

45

Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity

enthalten in: Journal of computer aided molecular design | 2019

von Zhu, K. | Shao, J. | Tao, H. | +4

46

Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity

enthalten in: Journal of computer aided molecular design | 2019

von Zhu, K. | Shao, J. | Tao, H. | +4

47

Discovery of 2-substituted-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxamide as potent and selective protein arginine methyltransferases 5 inhibitors : Design, synthesis and biological evaluation

enthalten in: European journal of medicinal chemistry | 2019

von Shao, J. | Zhu, K. | Du, D. | +7

48

CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer

enthalten in: Molecular carcinogenesis | 2019

von Zheng, N. | Liu, W. | Chen, J. | +6

49

Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α

enthalten in: Theranostics | 2019

von Zheng, B. | Ding, C. | Chen, S. | +11

50

Ursolic Acid in Cancer Treatment and Metastatic Chemoprevention : From Synthesized Derivatives to Nanoformulations in Preclinical Studies

enthalten in: Current cancer drug targets | 2019

von Zou, J. | Lin, J. | Li, C. | +4